Zeke Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,783
Closed -$274K 287
2019
Q4
$274K Sell
1,783
-211
-11% -$31.5K 0.02% 472
2019
Q3
$303K Buy
1,994
+6
+0.3% +$949 0.03% 455
2019
Q2
$304K Buy
1,988
+14
+0.7% +$2.14K 0.03% 464
2019
Q1
$317K Buy
1,974
+9
+0.5% +$1.4K 0.03% 459
2018
Q4
$303K Buy
+1,965
New +$306K 0.03% 433
2018
Q2
Sell
-2,229
Closed -$297K 648
2018
Q1
$297K Buy
2,229
+3
+0.1% +$403 0.03% 444
2017
Q4
$331K Buy
+2,226
New +$303K 0.03% 369

Other funds holding CLX

Zeke Capital Advisors's CLX Position: Q1 2020 in Review

Zeke Capital Advisors sold out of Clorox (CLX) in Q1 2020, closing a stake of 1,783 shares — an estimated $274K sold.

Zeke Capital Advisors first reported a position in CLX in Q4 2017 and held it in 7 quarters. The position peaked at $331K in Q4 2017. 1,119 funds tracked by Wall St. Rank hold CLX as of Q1 2020.

  • Zeke Capital Advisors reported no remaining Clorox position as of Q1 2020 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,783 Clorox shares in Q1 2020, an estimated $274K.
  • Zeke Capital Advisors first reported a position in Clorox in Q4 2017 and held it in 7 quarters.
  • Zeke Capital Advisors's Clorox position peaked at $331K in Q4 2017.
  • 1,119 funds tracked by Wall St. Rank held Clorox as of Q1 2020.

Based on Zeke Capital Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.